Form 4: Strata Critical Medical Co-CEO Sells Shares for Tax

Strata Critical Medical's Co-CEO and General Counsel, Melissa M. Tomkiel, disposed of 34,018 shares of Class A common stock to cover tax obligations related to restricted stock unit vesting.

Summary

• Melissa M. Tomkiel, who serves as Director, Co-CEO, and General Counsel of Strata Critical Medical, Inc. (SRTA), reported a transaction on December 10, 2025.
• The transaction involved the disposition of 34,018 shares of Class A common stock, with a par value of $0.0001 per share.
• These shares were withheld by Strata Critical Medical, Inc. to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
• The shares were valued at $4.38 per share for the purpose of this tax-related transaction.
• Following this reported transaction, Melissa M. Tomkiel directly beneficially owns 1,366,402 shares of Class A common stock.

Sentiment

Score: 5

Explanation: This Form 4 reports a routine insider transaction for tax withholding purposes related to restricted stock unit vesting, which is a common and expected event for executives and does not indicate a positive or negative sentiment towards the company's performance or outlook.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes, not indicative of a change in management's confidence or company fundamentals.
• Employees: No direct impact.
• Customers: No direct impact.
• Suppliers: No direct impact.
• Creditors: No direct impact.

Key Dates

Keywords

Strata Critical Medical, SRTA, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Melissa M. Tomkiel, Co-CEO, General Counsel